[go: up one dir, main page]

UY26307A1 - EFFICIENT SYNTHETIC ROUTES FOR THE PREPARATION OF RHINOVIRUS PROTEASE INHIBITORS AND KEY INTERMEDIATES - Google Patents

EFFICIENT SYNTHETIC ROUTES FOR THE PREPARATION OF RHINOVIRUS PROTEASE INHIBITORS AND KEY INTERMEDIATES

Info

Publication number
UY26307A1
UY26307A1 UY26307A UY26307A UY26307A1 UY 26307 A1 UY26307 A1 UY 26307A1 UY 26307 A UY26307 A UY 26307A UY 26307 A UY26307 A UY 26307A UY 26307 A1 UY26307 A1 UY 26307A1
Authority
UY
Uruguay
Prior art keywords
synthetic routes
preparation
key intermediates
protease inhibitors
efficient synthetic
Prior art date
Application number
UY26307A
Other languages
Spanish (es)
Inventor
Quingping Nayyar Bab Remarchuk
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Publication of UY26307A1 publication Critical patent/UY26307A1/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/2415—Tubular reactors
    • B01J19/2435—Loop-type reactors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/2475—Membrane reactors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
    • B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
    • B01J2219/00099—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor the reactor being immersed in the heat exchange medium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00159—Controlling the temperature controlling multiple zones along the direction of flow, e.g. pre-heating and after-cooling

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Las rutas sintéticas eficientes para la preparación del rinovirus de la fórmula I, así como también los intermedios claves útiles en esas rutas sintéticas. Los compuestos de la fórmula I, así como también las composiciones farmacéuticas que contienen esos compuestos, son adecuados para el tratamiento de pacientes o huéspedes infectados con uno o más picornavirus.Efficient synthetic routes for the preparation of the rhinovirus of formula I, as well as useful key intermediates in those synthetic routes. The compounds of formula I, as well as the pharmaceutical compositions containing those compounds, are suitable for the treatment of patients or hosts infected with one or more picornaviruses.

UY26307A 1999-08-24 2000-08-23 EFFICIENT SYNTHETIC ROUTES FOR THE PREPARATION OF RHINOVIRUS PROTEASE INHIBITORS AND KEY INTERMEDIATES UY26307A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15035899P 1999-08-24 1999-08-24

Publications (1)

Publication Number Publication Date
UY26307A1 true UY26307A1 (en) 2001-04-30

Family

ID=22534156

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26307A UY26307A1 (en) 1999-08-24 2000-08-23 EFFICIENT SYNTHETIC ROUTES FOR THE PREPARATION OF RHINOVIRUS PROTEASE INHIBITORS AND KEY INTERMEDIATES

Country Status (20)

Country Link
EP (1) EP1206450A1 (en)
JP (1) JP2003507453A (en)
KR (1) KR20020046283A (en)
CN (1) CN1168713C (en)
AR (1) AR025380A1 (en)
AU (1) AU770221B2 (en)
BR (1) BR0013306A (en)
CA (1) CA2376452A1 (en)
CO (1) CO5200782A1 (en)
CZ (1) CZ2002632A3 (en)
HK (1) HK1049336B (en)
HU (1) HUP0203365A3 (en)
IL (1) IL147674A0 (en)
MX (1) MXPA02001944A (en)
PE (1) PE20010517A1 (en)
PL (1) PL353997A1 (en)
TW (1) TWI245040B (en)
UY (1) UY26307A1 (en)
WO (1) WO2001014329A1 (en)
ZA (1) ZA200200504B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL138609A0 (en) 1998-04-30 2001-10-31 Agouron Pharma Antipicornaviral compounds, their preparation and use
HUP0203108A3 (en) 1999-08-04 2004-07-28 Agouron Pharmaceuticals Inc La Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
PE20020157A1 (en) 1999-12-03 2002-02-22 Agouron Pharma PYRIDONE DERIVED COMPOUNDS AS PICORNAVIRAL 3C PROTEASE INHIBITORS, COMPOSITIONS, THEIR PHARMACEUTICAL USES AND MATERIALS FOR THEIR SYNTHESIS
PA8515201A1 (en) 2000-04-14 2002-10-24 Agouron Pharma ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS; YOUR PHARMACEUTICAL USES AND MATERIALS FOR SYNTHESIS
BR0111727A (en) 2000-06-14 2003-05-27 Agouron Pharma Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
CN1309712C (en) * 2004-04-02 2007-04-11 中国科学院上海有机化学研究所 Precursor of key intermediate of AG 7088 class compound and its sythetic process
US20230157998A1 (en) 2020-03-06 2023-05-25 Pfizer Inc. Methods of Inhibiting SARS-CoV-2 Replication and Treating Corona Virus Disease 2019
CN115260074B (en) * 2022-08-02 2024-06-21 爱斯特（成都）生物制药股份有限公司 Preparation method of oral antiviral drug Paxlovid intermediate
CN115322130B (en) * 2022-08-02 2024-05-14 南京正济医药研究有限公司 Preparation of (S) -2- (BOC-amino) -3- [ (S) -2-oxo-3-pyrrolidinyl ] propanoic acid methyl ester

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000506903A (en) * 1996-05-14 2000-06-06 アグロン・ファーマシュウティカルズ・インコーポレーテッド Inhibitors of picornavirus 3C protease and methods of using and producing them
CA2289541A1 (en) * 1997-03-28 1998-10-08 Peter S. Dragovich Antipicornaviral compouds, compositions containing them, and methods for their use
US5962487A (en) * 1997-12-16 1999-10-05 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and methods for their use and preparation
IL138609A0 (en) * 1998-04-30 2001-10-31 Agouron Pharma Antipicornaviral compounds, their preparation and use

Also Published As

Publication number Publication date
HUP0203365A3 (en) 2003-12-29
JP2003507453A (en) 2003-02-25
AU770221B2 (en) 2004-02-19
PE20010517A1 (en) 2001-05-16
MXPA02001944A (en) 2002-10-31
CA2376452A1 (en) 2001-03-01
CN1168713C (en) 2004-09-29
WO2001014329A1 (en) 2001-03-01
CN1374947A (en) 2002-10-16
TWI245040B (en) 2005-12-11
CZ2002632A3 (en) 2003-04-16
BR0013306A (en) 2002-05-28
KR20020046283A (en) 2002-06-20
HK1049336B (en) 2005-05-20
AU6797100A (en) 2001-03-19
HUP0203365A2 (en) 2003-02-28
AR025380A1 (en) 2002-11-20
HK1049336A1 (en) 2003-05-09
EP1206450A1 (en) 2002-05-22
CO5200782A1 (en) 2002-09-27
IL147674A0 (en) 2002-08-14
ZA200200504B (en) 2003-03-26
PL353997A1 (en) 2003-12-15

Similar Documents

Publication Publication Date Title
PA8496301A1 (en) METALOPROTEASE INHIBITORS.
UY26886A1 (en) POLYMORPHES OF AN EPOTILONE ANALOG
PA8468401A1 (en) COMPOUNDS FOR THE TREATMENT OF ISCHEMIA
UY27446A1 (en) NEW COMPOUNDS
UY27333A1 (en) NUCLEOTIDOS 4` REPLACED
PA8493701A1 (en) COMPOUNDS TO TREAT OBESITY
CY1116103T1 (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
ECSP055801A (en) BENZOFURANIC COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROFILAXIS OF HEPATITIS C VIRAL INFECTIONS AND ASSOCIATED DISEASES
UY28691A1 (en) DERIVATIVES OF DIFENILAZETIDONA
ECSP003682A (en) COMPOUNDS FOR THE TREATMENT OF THE ISCHEMIA
AR030540A1 (en) ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USE, AND MATERIALS FOR SYNTHESIS
UY28885A1 (en) 4-PHENYLAMINE-QUINAZOLIN-6-IL-AMIDAS CROSSED REFERENCE ON RELATED APPLICATION (S)
CR7716A (en) USE OF IKB-KINASE INHIBITORS FOR PAIN TREATMENT
UY29087A1 (en) ADAMANTILE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USE
AR047529A1 (en) SUBSTITUTED QUINOLINE COMPOUNDS
PT1206484E (en) ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES AND MATERIALS FOR THEIR SYNTHESIS
HN2003000162A (en) DERIVATIVES OF ISOINDOLONE, PREPARATION PROCESS AND INTERMEDIATE COMPOUNDS OF THIS PROCESS, ITS USE AS MEDICATIONS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
PA8561501A1 (en) LACTAMAS AS TAQUIQUININE ANTAGONISTS
UY26307A1 (en) EFFICIENT SYNTHETIC ROUTES FOR THE PREPARATION OF RHINOVIRUS PROTEASE INHIBITORS AND KEY INTERMEDIATES
CO6640204A2 (en) Derivatives of (methylsulfonyl) ethylbenzene isoindoline and its therapeutic uses
ECSP034531A (en) SUBSTITUTED DERIVATIVES OF C-CICLOHEXILMETILAMINA
HUP0200152A2 (en) Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites
EA200870090A1 (en) APPLICATION OF DERIVATIVES OF SULFAMIDE INCLUDING A HETEROCYCL CONDENSED WITH A BENZEN RING FOR THE TREATMENT OF DEPRESSION
DOP2010000197A (en) OXINDOL DERIVATIVES SUBSTITUTED AND USE OF THE SAME FOR THE TREATMENT OF VASOPRESINE DEPENDENT DISEASES
AR035110A1 (en) COMPOSITE DERIVED FROM PIPERAZINE, USE OF THE SAME FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND PROCEDURE FOR THE PREPARATION OF SUCH COMPOUND

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20110721